RIG-I is an intracellular checkpoint that limits CD8+ T-cell antitumour immunity

Authors: Xiaobing Duan, Jiali Hu, Yuncong Zhang, Xiaoguang Zhao, Mingqi Yang, Taoping Sun, Siya Liu, Xin Chen, Juan Feng, Wenting Li, Ze Yang, Yitian Zhang, Xiaowen Lin, Dingjie Liu, Ya Meng, Guang Yang, Qiuping Lin, Guihai Zhang, Haihong Lei, Zhengsheng Yi, Yanyan Liu, Xiaobing Liang, Yujuan Wu, Wenqing Diao, Zesong Li, Haihai Liang, Meixiao Zhan, Hong-Wei Sun, Xian-Yang Li, Ligong Lu

Source: EMBO Molecular Medicine, Vol 16, Iss 11, Pp 3005-3025 (2024)

Subject Terms: RIG-I, CD8+ T cells, Immune Checkpoint, AKT/Glycolysis Signalling Pathway, Immunotherapy, Medicine (General), R5-920, Genetics, QH426-470

File Description: electronic resource

Relation: https://doaj.org/toc/1757-4684

Access URL: https://doaj.org/article/59d8b008363244d1ad0a57728bdc6b90

Neonatal-onset carbamoyl phosphate synthetase I deficiency: A case report.

Authors: Xiaoyan Yang, Jing Shi, Haihong Lei, Bin Xia, Dezhi Mu, Yang, Xiaoyan, Shi, Jing, Lei, Haihong, Xia, Bin, Mu, Dezhi

Source: Medicine; 6/30/2017, Vol. 96 Issue 26, p1-4, 4p